These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18992310)

  • 21. Plasma concentrations of S-verapamil after single doses of two different galenic formulations of racemic verapamil.
    Harder S; Siewert M; Thürmann P; Blume H; Rietbrock N; Siewert B
    Arzneimittelforschung; 1993 May; 43(5):520-2. PubMed ID: 8328995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
    Lennernäs H
    Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tableting of floating pellets with verapamil hydrochloride: influence of type of tablet press.
    Sawicki W; Łunio R
    Acta Pol Pharm; 2010; 67(1):103-6. PubMed ID: 20210087
    [No Abstract]   [Full Text] [Related]  

  • 25. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J; Vanderbist F; Amighi K
    Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The design of controlled-release formulations resistant to alcohol-induced dose dumping--a review.
    Jedinger N; Khinast J; Roblegg E
    Eur J Pharm Biopharm; 2014 Jul; 87(2):217-26. PubMed ID: 24613542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
    Jedinger N; Schrank S; Mohr S; Feichtinger A; Khinast J; Roblegg E
    Eur J Pharm Biopharm; 2015 May; 92():83-95. PubMed ID: 25733499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of acrylic esters and methacyrlic esters on flotation of pellets and release rate of verapamil hydrochloride.
    Lunio R; Sawicki W
    Acta Pol Pharm; 2006; 63(1):69-74. PubMed ID: 17515332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel chewable sustained-release tablet containing verapamil hydrochloride.
    El-Gazayerly ON; Rakkanka V; Ayres JW
    Pharm Dev Technol; 2004; 9(2):181-8. PubMed ID: 15202577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
    Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
    Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of floating pellets with verapamil hydrochloride.
    Sawicki W; Głód J
    Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
    Sun Y; Rui Y; Wenliang Z; Tang X
    Int J Pharm; 2008 Jul; 359(1-2):144-9. PubMed ID: 18499371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.
    Dürig T; Fassihi R
    J Control Release; 2000 Jun; 67(1):37-44. PubMed ID: 10773327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.
    Popović J; Mitić R; Sabo A; Mikov M; Jakovljević V; Daković-Svajcer K
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):87-96. PubMed ID: 16898076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms.
    Lin Z; Zhou D; Hoag S; Qiu Y
    AAPS J; 2016 Mar; 18(2):333-45. PubMed ID: 26769249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution.
    Kayumba PC; Risha PG; Shewiyo D; Msami A; Masuki G; Ameye D; Vergote G; Ntawukuliryayo JD; Remon JP; Vervaet C
    J Clin Pharm Ther; 2004 Aug; 29(4):331-8. PubMed ID: 15271100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.